MYOF and pancreatic adenocarcinoma: Specifically, myoferlin is an independent prognostic factor in pancreatic adenocarcinoma,36, 43 oropharyngeal squamous cell carcinoma,45 head and neck squamous cell carcinoma patients,45, 61 clear cell renal cell carcinoma,47 colon cancer38 and non‐small‐cell lung carcinoma42 patients.